To hear about similar clinical trials, please enter your email below
Trial Title:
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT ID:
NCT02105168
Condition:
Melanoma
Non Small Cell Lung Cancer
Small Cell Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Melanoma
Small Cell Lung Carcinoma
Study type:
Interventional
Study phase:
N/A
Overall status:
Unknown status
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Screening
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Blood sample
Description:
Optional
Arm group label:
Experimental arm
Intervention type:
Procedure
Intervention name:
Tumorous biopsy
Description:
Optional
Arm group label:
Experimental arm
Intervention type:
Procedure
Intervention name:
Healthy material sample
Description:
Optional
Arm group label:
Experimental arm
Summary:
Lung Cancer and melanoma relapsed frequently whereas its very sensitive to treatment such
as chemotherapy or radiotherapy. The purpose of this study is to have a better
understanding of why those patients are relapsing using next generation sequencing to
identify rare mutations and assessed their predictive value.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Cytological or histological diagnosis of SCLC, NSCLC or melanoma
2. Patients age >/= 18 years old
3. Indication of treatment using platinum salts for lung cancer except for patient with
NSCLC treated by surgery for whom platinum salts is not indicated
4. If a biopsy is proposed, lesion lust be easily accessible
5. Signed informed consent
Exclusion Criteria:
1. Patients unable to follow the protocol
2. Consent refusal
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Gustave Roussy Cancer Campus Grand Paris
Address:
City:
Villejuif
Zip:
94805
Country:
France
Status:
Recruiting
Contact:
Last name:
Benjamin Besse, MD
Phone:
0142114317
Phone ext:
+33
Email:
benjamin.besse@gustaveroussy.fr
Investigator:
Last name:
Caroline Robert, MD
Email:
Principal Investigator
Start date:
July 2009
Completion date:
July 2019
Lead sponsor:
Agency:
Gustave Roussy, Cancer Campus, Grand Paris
Agency class:
Other
Source:
Gustave Roussy, Cancer Campus, Grand Paris
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT02105168
